<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04567134</url>
  </required_header>
  <id_info>
    <org_study_id>HYUH 2020-06-046</org_study_id>
    <nct_id>NCT04567134</nct_id>
  </id_info>
  <brief_title>Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea</brief_title>
  <official_title>Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hanyang University Seoul Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korean Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hanyang University Seoul Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our objective of this study is to derive a real incidence of CDI in tertiary hospitals&#xD;
      located through Korean peninsula. In order to get a close value to the truth, the study is&#xD;
      planned to co-perform with a national study which was proposed in evaluation process to&#xD;
      include more hospitals. Along with the incidence of CDI, clinical characteristics and outcome&#xD;
      of CDI will be examined and microbiologic characteristics of C. difficile isolates from CDI&#xD;
      patients are studied.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of CDI</measure>
    <time_frame>through Oct 2020 to Dec 2021</time_frame>
    <description>Incidence of CDI among hospitalized adults per 100,000 patient*days/10,000 patient*admission in enrolled tertiary hospitals.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality rate</measure>
    <time_frame>through Oct 2020 to May 2022</time_frame>
    <description>Proportion of CDI cases who died during the 60-day follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>through Oct 2020 to May 2022</time_frame>
    <description>Proportion of CDI cases with recurrence/reinfection between Day 14 and Day 60</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Clostridium Difficile Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      C. difficile isolates&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The patients who admitted at the tertiary hospitals in Korea and and diagnosed as&#xD;
        Clostridioides difficile infection will be selected.&#xD;
&#xD;
        The tertiary hospitals located in Seoul-si, Gyeonggi-do, Pusan-si, Daegu-si, Jeollanam-do,&#xD;
        Jeollabuk-do, and Chungcheongbuk-do. These hospitals distributes all over the country.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged older than 19 years&#xD;
&#xD;
          -  more than 3 times of unformed stools passage per day&#xD;
&#xD;
          -  positive results of toxin gene test: GDH (+) + PCR (+), GDH (+) + toxin (+), or PCR&#xD;
             (+) + toxin (+)&#xD;
&#xD;
          -  agree with informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  less than 3 times of unformed stool passage per day&#xD;
&#xD;
          -  use of oral metronidazole or vancomycin more than 24 hours before enrollment&#xD;
&#xD;
          -  use of laxative before enrollment&#xD;
&#xD;
          -  recurrent episode of CDI&#xD;
&#xD;
          -  disagree with study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyunjoo Pai, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Hanyang University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyunjoo Pai, M.D., Ph.D.</last_name>
    <phone>+82-2-2290-8356</phone>
    <email>paihyunjoo@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jieun Kim, M.D., Ph.D.</last_name>
    <phone>+82-31-560-2249</phone>
    <email>quidam76@hanyang.ac.kr</email>
  </overall_contact_backup>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>September 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clostridium difficile</keyword>
  <keyword>incidence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Clostridium Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

